1/32
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai | Chat |
|---|
No analytics yet
Send a link to your students to track their progress
bromelain
cysteine protease - has little preference for specific protein sequences and cleaves at many amide bonds
in pineapple
trypsin
cleaves amide bond at C-terminal of Lys or Arg
thrombin
cleaves only between Arg-Gly bonds in certain recognition sequences
lock and key model
enzyme has a specific shape that binds to specific substrates
induced fit
enzyme undergoes conformational changes to fit different substrates
do enzymes change reaction equilibrium
no, only reaction rate
why does transglutaminase form amide bonds but proteases hydrolyze them?
enzymes catalyze both forward and reverse reactions
→ transglutaminase don’t FORM amide bonds, they are creating an amide exchange, which is a different reaction with different thermodynamics
how are enzymes regulated?`
changing enzyme bioavailability through protein synthesis (ex. RNA splicing)
catalytic efficiency through enzyme modifications
how do you change enzyme bioavailability
RNA processing, protein targeting, protein degredation
how do you change catalytic efficiency through protein modifications
binding of regulatory molecules, covalent modification, proteolytic processing
six ways cells regulate enzyme activity
binding of regulatory molecules at regulatory sites, including allostery: turns on and off the enzyme
isozymes: there are differnet times of enzymes for different tissues or organelles
covalent modification: phosphorylation, acetylation, etc
proteolytic activation: zymogens
proteolytic degradation: proteases and the proteosome
control of enzyme biosynthesis via gene expression
distribution of DFA drug approvals
enzymes - 17%
kinases - 16%
GPCR - 12%
transporter - 4.0%
nuclear R - 3.7%
others - 47.3%
irreversible enzyme inhibition
inhibitory molecule forms a covalent bond with the catlytic group in the active site
→ kills the enzyme
reversible enzyme inhibition
nonconvalent bonding of a small biomolecules or proteins to the enzyme
inhibition is decreased by diluting the enzyme reaction
what are the 3 types of reversible enzyme inhibition
competitive, uncompetitive, and mixed
example of irreversible enzyme inhibition
DFP on catalytic Ser195 in chymotrypsin
competitive inhibition
inhibitor replaces the substrate at the active side

uncompetitve inhibition
inhibitor binds to another site of the enzyme AFTER THE SUBSTRATE IS BOUND and blocks product formation

mixed inhibition
the inhibitor bind to just enzyme or ES complex, doesn’t bind to active site
kinetic parameters for competitive inhibition
can be overcome by increasing [S]
Vmax is unchanged, but Km increases
![<ul><li><p>can be overcome by increasing [S]</p></li><li><p>V<sub>max</sub> is unchanged, but K<sub>m</sub> increases</p></li></ul><p></p>](https://assets.knowt.com/user-attachments/8764448d-7634-4ab9-9661-acaf8f5f2e51.png)
what is Km, app?
Km when there is an inhibitor; strength of the inhibitor
equation only applies to competitive inhibitors

how to calculate Vo
Vo = K2 [ES]
![<p>V<sub>o</sub> = K<sub>2</sub> [ES]</p><p></p>](https://assets.knowt.com/user-attachments/96647a93-d85e-4dfb-9054-caedc75e83cf.png)
KI

how to calculate [ES]

kinetic parameters for uncompetitive inhibition
Km is constant and Vmax decrease
→ but Km, app decreases

mixed inhibition
lowers Vmax and may increase or decrease Km
Km can also stay the same → special case their the binding of the substrate doesn’t influence the inhibitor binding
noncompetitive inhibition
Ki = Ki’ → where Km stays the same in mixed inhibition
equations for kinetic parameters of different types of inhibition

Km
strength of the ES complex
what will change Km
something that will change binding affinity between the enzyme and the substrate
ATCase
allosteric regulation
has an active and inactive from switched on by ATP and switched off by CTP
inhibited by the end product of its pathway
ATCase kinetics
sigmoidal curve (cooperativity): the bidning of substrate to one active site increases activity at another active site
*do not follow Michaelis-Menten kinetics
If K2 is as large as possible, can uncompetitive inhibitors bind?
yes, but they have to bind faster than produce release